Hydrosalpinx - Salpingostomy, salpingectomy or tubal occlusion.
Hydrosalpinx
IVF
Natural conception
Salpingectomy
Salpingostomy
Tubal occlusion
Journal
Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
30
11
2018
revised:
02
01
2019
accepted:
21
01
2019
pubmed:
3
3
2019
medline:
7
2
2020
entrez:
3
3
2019
Statut:
ppublish
Résumé
Tubal factors account for approximately 25% of cases of infertility, and the most severe manifestation of tubal disease is hydrosalpinx, accounting for 10-30% of tubal diseases. Hydrosalpinx is a distension or dilatation of the fallopian tube in the presence of a distal tubal occlusion, and the most common cause is pelvic inflammatory disease. Women with hydrosalpinges have lower implantation and pregnancy rates in assisted reproductive technology (ART), due to a combination of mechanical and chemical factors thought to disrupt the endometrial environment. Current guidance is removal of the tube by salpingectomy (preferably laparoscopically) before IVF treatment. Salpingostomy, or distal tubal plastic surgery in the management of hydrosalpinx, is an alternative for women desiring natural conception, although ectopic pregnancy rates as high as 10% have been reported. Proximal tubal occlusion with Essure
Identifiants
pubmed: 30824209
pii: S1521-6934(18)30261-X
doi: 10.1016/j.bpobgyn.2019.01.011
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
41-47Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.